We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App


31 Jul 2024 - 02 Aug 2024
02 Aug 2024 - 04 Aug 2024
20 Aug 2024 - 22 Aug 2024

AI Robotic System Selectively Kills Microscopic Tumor Cells without Damaging Surrounding Tissue

By HospiMedica International staff writers
Posted on 25 Sep 2023
Print article
Image: The Canady Robotic AI Surgical System (Photo courtesy of JCRI-ABTS)
Image: The Canady Robotic AI Surgical System (Photo courtesy of JCRI-ABTS)

When treating cancer, surgeons usually aim to remove the tumor along with a surrounding "margin" of healthy tissue to make sure all cancer cells have been taken out. However, even with advancements in different types of treatments like surgery, chemotherapy, and immunotherapy, there's still no absolute assurance that microscopic cancer cells aren't left behind in the surgical margins. These lingering cells can contribute to cancer returning and worsen survival rates. Now, the world’s first AI robotic system selectively targets and kills microscopic tumor cells during surgery without damaging non-cancerous surrounding tissue.

The Canady Robotic AI Surgical System from the Jerome Canady Research Institute for Advanced and Biological Technological Sciences (JCRI-ABTS, Takoma Park, MD, USA) and US Medical Innovations, LLC (USMI, Takoma Park, MD, USA) marks a ground-breaking achievement in surgical and robotic technology. The Canady Robotic AI Surgical System delivers cold atmospheric plasma (CAP) which is a three-dimensional non-contact bioelectric pulse electromagnetic field that selectively targets cancer cells at the surgical margin.

The key components of the Canady Robotic AI Surgical System include a motorized positioning arm, speech recognition Canady electrosurgical generator known as ORLI, controller for CAP devices, robotic-assisted end effectors which can be used in open, laparoscopic, thoracoscopic, endoscopic, and mini-invasive surgical procedures. The system also provides surgeons with 10 degrees of freedom, speech activation of the robotic movements, AI-powered software programs, 3D navigational guided surgical planning, advanced contour tracking of the CAP beam, and pre-programmed CAP dosimetry data for selectively targeting 32 cancer cell types, all in a compact and mobile design.

“This technology will transform the landscape of the OR. ORLI is a user-friendly system controlling the entire integrated SMART Operating Room. The platform will serve as a SIRI, ALEXA, and GOOGLE HOME for the operating room,” said Jerome Canady, MD, FACS, CEO and Surgical Oncologist. “Data collected from our recent FDA Phase 1 Clinical Trial on Stage 4 Cancer Patients combined with ten years of in-vitro translational molecular research data have been imported into the Canady Robotic AI Surgical System. This achievement signifies a significant leap forward integrating artificial intelligence and robotics in surgery.”

Related Links:

Gold Member
Solid State Kv/Dose Multi-Sensor
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
Wireless Mobile ECG Recorder
Portable Single Breath DLCO Device
EasyOne Pro

Print article


Critical Care

view channel
Image: The first healthcare device to be powered by body heat was made possible by the use of liquid-based metals (Photo courtesy of Carnegie Mellon)

Healthcare Device Powered By Body Heat Marks First Step Toward Battery-Free Wearable Electronics

Portable, wearable electronics for physiological monitoring are gaining preference over traditional tethered devices in clinical settings due to their convenience for continuous or frequent monitoring.... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: POCT offers cost-effective, accessible, and immediate diagnostic solutions (Photo courtesy of Flinders University)

POCT for Infectious Diseases Delivers Laboratory Equivalent Pathology Results

On-site pathology tests for infectious diseases in rural and remote locations can achieve the same level of reliability and accuracy as those conducted in hospital laboratories, a recent study suggests.... Read more


view channel
Image: The Innovalve transseptal delivery system is designed to enable safe deployment of the Innovalve implant (Photo courtesy of Innovalve Bio)

Edwards Lifesciences Acquires Sheba Medical’s Innovalve Bio Medical

Edwards Lifesciences (Irvine, CA, USA), a leading company in medical innovations for structural heart disease and critical care, has acquired Innovalve Bio Medical LTD. (Ramat Gan, Israel), an early-stage... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.